As of 22 Sept 2026, Rekvina Labs Ltd share price is ₹53.84. The stock opened at ₹53.84 and had closed at ₹54.93 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹6.75 and a high of ₹59.40. In terms of performance, Rekvina Labs Ltd share price has increased by 31.61% over the past six months and has increased by 660.45% over the last year.
Rekvina Labs Stock Price Chart
Rekvina Labs Ltd Overview
About Rekvina Labs
Rekvina Labs engaged in providing comprehensive diagnostic and testing services, including clinical pathology, biochemistry, microbiology, molecular diagnostics, and advanced imaging. The company operates with a commitment to accuracy, reliability, and innovation in medical testing, supported by state-of-the-art laboratory technology and a team of highly skilled professionals. By upholding the highest standards of quality and precision and plays a vital role in disease detection, prevention, and treatment support, serving hospitals, clinics, and individual patients with trusted diagnostic solutions.
Rekvina Labs Ltd Historical Performance
Rekvina Labs Ltd Fundamentals
Rekvina Labs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1.27 | - | - | - | - |
| EBITDA | -0.25 | -0.14 | -0.02 | - | -0.08 |
| Net Profit | -0.25 | -0.14 | -0.02 | - | -0.08 |
| EPS | -0.42 | -0.23 | -0.03 | - | -0.13 |
Rekvina Labs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 54.93 |
| Resistance 1 (R1) | 54.93 |
| Pivot Point | 54.93 |
Rekvina Labs Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| ILA RAJENDRA PATHAK | Chairman |
| Amit Mukeshbhai Shah | Managing Director |
| Surbhit Shah | Chief Financial Officer |
Rekvina Labs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Rekvina Labs Ltd today is ₹53.84 on NSE and ₹53.84 on BSE.
- The 52-week high of Rekvina Labs Ltd is ₹59.40, while the 52-week low is ₹6.75.
- The current market capitalisation of Rekvina Labs Ltd is approximately ₹60 crore.
- The P/E (Price-to-Earnings) ratio of Rekvina Labs Ltd is -173.68. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Rekvina Labs Ltd is 15.51. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Rekvina Labs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Rekvina Labs on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Rekvina Labs Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Rekvina Labs Ltd comprises different categories of shareholders. As of Aug 2026, the shareholding is approximately 77.00% promoters, 0.00% FIIs, 0.00% DIIs, and 18.96% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
